نظرة عامة على البرنامج

Introduction to Therapeutics in Practice 3A

The Therapeutics in Practice 3A unit, coded as CSA322, is designed to build upon existing knowledge of pharmacology, physiology, microbiology, and evidence-based health. This unit aims to develop the clinical knowledge and skills necessary for delivering pharmaceutical care.

Unit Details

• Unit Name: Therapeutics in Practice 3A
• Unit Code: CSA322
• Credit Points: 25
• College/School: Health
• School of Pharmacy and Pharmacology
• Discipline: Pharmacy
• Coordinator: Mrs Kendall Stephens
• Available as an Elective: No
• Delivered By: University of Tasmania
• Level: Advanced

Availability

The unit is available at the following locations and study periods:

• Cradle Coast: Semester 1
• Hobart: Semester 1
• Launceston: Semester 1

Key Dates

• Study Period: Semester 1
• Start Date: 23/2/2026
• Census Date: 17/3/2026
• WW Date: 20/4/2026
• End Date: 14/6/2026

Learning Outcomes

Upon completion of this unit, students will be able to:

• Outline the common presenting features of acute and chronic conditions/diseases.
• Identify medication-related problems and/or health issues that may actually or potentially impact the patient.
• Design patient-centred therapeutic plans that incorporate appropriate monitoring strategies and non-pharmacological interventions to enhance health outcomes.
• Interpret diagnostic and clinical data to inform and optimise patient care.

Fee Information

• Field of Education:
• Commencing Student Contribution: $2,384.00
• Grandfathered Student Contribution: $2,384.00
• Approved Pathway Course Student Contribution: Not applicable
• Domestic Full Fee: $5,724.00

Requisites

Prerequisites

• CSA231
• CSA209
• CSA208

Concurrent Prerequisites

• CSA207

Teaching

• Teaching Pattern: 3 hour workshop weekly, 1 hour online seminar, 6 hours self-directed online learning activities
• Assessment: In-workshop clinical case assessments (30%), Mid-semester written test (30%), Written exam (40%)

Textbooks

• Required: Any required readings will be provided by the Unit Coordinator.
• Recommended: DiPiro et al. Pharmacotherapy: A Pathophysiologic Approach. McGraw-Hill Medical (12th Edition)

Additional resources include:

• Australian Medicines Handbook (AMH), PSA/RACGP/ASCEPT
• Therapeutic Guidelines (TG), Therapeutic Guidelines Ltd
• UpToDate

Related Units

• Therapeutics in Practice 3B CSA306
• Transition to Pharmacy Practice 3 CSA307
• Clinical Pharmacy Research CSA321
• Clinical Toxicology and Medicine Safety CSA326
• Drug Discovery, Development and Delivery CSA327
• Innovation in Medicine Safety CSA328
• Therapeutics of Infectious Disease CSA329
• Pharmacy Skills in Practice 3A CSA355
• Pharmacy Skills in Practice 3B CSA357